SpaceX’s Healthcare Plays
In this week’s edition of InnovationRx, we look at SpaceX’s hopes for healthcare, the AI drug discovery startup…
Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup
Chai Discovery cofounders Josh Meier (left) and Jack Dent Cody Pickens for Forbes L ast June, when AI…
From OpenAI’s offices to a deal with Eli Lilly — how Chai Discovery became one of the flashiest names in AI drug development
Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process.…
OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation
Chai Discovery, a biotech startup with backing from OpenAI, announced a $130 million Series B round at a…